World Journal of Radiology (World J Radiol

REFERENCES
1 Parkin DM. The global health burden of infection-associated
cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044
2 Carbone M, Pass HI, Miele L, Bocchetta M. New developments
about the association of SV40 with human mesothelioma.
Oncogene 2003; 22: 5173-5180
3 McLaughlin-Drubin ME, Munger K. Viruses associated
with human cancer. Biochim Biophys Acta 2008; 1782: 127-150
4 Epstein MA, Henle G, Achong BG, Barr YM. Morphological
and biological studies on a virus in cultured lymphoblasts
from Burkitt’s lymphoma. J Exp Med 1965; 121: 761-770
5 Andersson J. An Overview of Epstein-Barr Virus: from Discovery
to Future Directions for Treatment and Prevention.
Herpes 2000; 7: 76-82
6 Thorley-Lawson DA. EBV the prototypical human tumor
virus--just how bad is it? J Allergy Clin Immunol 2005; 116:
251-261; quiz 262
7 Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses
to viral infection in humans: lessons from Epstein-
Barr virus. Annu Rev Immunol 2007; 25: 587-617
8 Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virusassociated
Hodgkin’s lymphoma. Br J Haematol 2004; 125:
267-281
9 Mani H, Jaffe ES. Hodgkin lymphoma: an update on its
biology with new insights into classification. Clin Lymphoma
Myeloma 2009; 9: 206-216
10 Lee KS, Kim Y, Primack SL. Imaging of pulmonary lymphomas.
AJR Am J Roentgenol 1997; 168: 339-345
11 Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and
Burkitt lymphoma. J Clin Pathol 2007; 60: 1397-1402
12 Munn S. Imaging HIV/AIDS. Burkitt’s lymphoma. AIDS
Patient Care STDS 2002; 16: 395-399
13 Orem J, Maganda A, Mbidde EK, Weiderpass E. Clinical
characteristics and outcome of children with Burkitt lymphoma
in Uganda according to HIV infection. Pediatr Blood
Cancer 2009; 52: 455-458
14 Abramson SJ, Price AP. Imaging of pediatric lymphomas.
Radiol Clin North Am 2008; 46: 313-338, ix
15 Nzeh DA. Atypical intrathoracic manifestations of Burkitt’s
lymphoma. Pediatr Radiol 1988; 18: 411-412
16 Boshoff C, Weiss R. AIDS-related malignancies. Nat Rev
Cancer 2002; 2: 373-382
17 Sider L, Weiss AJ, Smith MD, VonRoenn JH, Glassroth J.
Varied appearance of AIDS-related lymphoma in the chest.
Radiology 1989; 171: 629-632
18 Styczynski J, Einsele H, Gil L, Ljungman P. Outcome of
treatment of Epstein-Barr virus-related post-transplant
lymphoproliferative disorder in hematopoietic stem cell recipients:
a comprehensive review of reported cases. Transpl
Infect Dis 2009; 11: 383-392
19 Collins J, Müller NL, Leung AN, McGuinness G, Mergo PJ,
Flint JD, Warner TF, Poirier C, Theodore J, Zander D, Yee
HT. Epstein-Barr-virus-associated lymphoproliferative disease
of the lung: CT and histologic findings. Radiology 1998;
208: 749-759
20 Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z. Posttransplantation
lymphoproliferative disorder: the spectrum
of imaging appearances. Clin Radiol 2005; 60: 47-55
21 Allen-Auerbach M, de Vos S, Czernin J. The impact of fluorodeoxyglucose-positron
emission tomography in primary
staging and patient management in lymphoma patients.
Radiol Clin North Am 2008; 46: 199-211, vii
22 Marom EM, McAdams HP, Butnor KJ, Coleman RE. Posi- Positron
emission tomography with fluoro-2-deoxy-D-glucose
(FDG-PET) in the staging of post transplant lymphoproliferative
disorder in lung transplant recipients. J Thorac Imaging
2004; 19: 74-78
23 McCormack L, Hany TI, Hübner M, Petrowsky H, Mullhaupt
B, Knuth A, Stenner F, Clavien PA. How useful is
WJR|www.wjgnet.com
Restrepo CS et al . Infectious chest tumors
PET/CT imaging in the management of post-transplant
lymphoproliferative disease after liver transplantation? Am
J Transplant 2006; 6: 1731-1736
24 von Falck C, Maecker B, Schirg E, Boerner AR, Knapp WH,
Klein C, Galanski M. Post transplant lymphoproliferative
disease in pediatric solid organ transplant patients: a possible
role for [18F]-FDG-PET(/CT) in initial staging and
therapy monitoring. Eur J Radiol 2007; 63: 427-435
25 Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative
disorders. Hum Pathol 2007; 38: 1293-1304
26 Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatogranulomatosis:
radiologic features and pathologic correlations. AJR Am
J Roentgenol 2000; 175: 1335-1339
27 Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid
granulomatosis: a clinicopathologic study of 152 cases.
Cancer 1979; 43: 360-373
28 Benamore RE, Weisbrod GL, Hwang DM, Bailey DJ, Pierre
AF, Lazar NM, Maimon N. Reversed halo sign in lymphomatoid
granulomatosis. Br J Radiol 2007; 80: e162-e166
29 McCloskey M, Catherwood M, McManus D, Todd G, Cuthbert
R, Riley M. A case of lymphomatoid granulomatosis
masquerading as a lung abscess. Thorax 2004; 59: 818-819
30 Jaffre S, Jardin F, Dominique S, Duet E, Hubscher P, Genevois
A, Corne F, Bota S, Nouvet G, Thiberville L. Fatal haemoptysis
in a case of lymphomatoid granulomatosis treated
with rituximab. Eur Respir J 2006; 27: 644-646
31 Moore PS, Chang Y. Detection of herpesvirus-like DNA
sequences in Kaposi’s sarcoma in patients with and without
HIV infection. N Engl J Med 1995; 332: 1181-1185
32 Liang C, Lee JS, Jung JU. Immune evasion in Kaposi’s sarsarcoma-associated herpes virus associated oncogenesis. Semin
Cancer Biol 2008; 18: 423-436
33 Cronin DM, Warnke RA. Castleman disease: an update on
classification and the spectrum of associated lesions. Adv
Anat Pathol 2009; 16: 236-246
34 Schulz TF. The pleiotropic effects of Kaposi’s sarcoma herpesvirus.
J Pathol 2006; 208: 187-198
35 Carbone A, Gloghini A. AIDS-related lymphomas: from
pathogenesis to pathology. Br J Haematol 2005; 130: 662-670
36 Restrepo CS, Martínez S, Lemos JA, Carrillo JA, Lemos DF,
Ojeda P, Koshy P. Imaging manifestations of Kaposi sarcoma.
Radiographics 2006; 26: 1169-1185
37 Gasparetto TD, Marchiori E, Lourenço S, Zanetti G, Vianna
AD, Santos AA, Nobre LF. Pulmonary involvement in KaKaposi sarcoma: correlation between imaging and pathology.
Orphanet J Rare Dis 2009; 4: 18
38 Palmieri C, Dhillon T, Thirlwell C, Newsom-Davis T,
Young AM, Nelson M, Gazzard BG, Bower M. Pulmonary
Kaposi sarcoma in the era of highly active antiretroviral
therapy. HIV Med 2006; 7: 291-293
39 Castleman B, Iverson L, Menendez VP. Localized mediastinal
lymphnode hyperplasia resembling thymoma. Cancer
1956; 9: 822-830
40 Hillier JC, Shaw P, Miller RF, Cartledge JD, Nelson M,
Bower M, Francis N, Padley SP. Imaging features of multicentric
Castleman’s disease in HIV infection. Clin Radiol
2004; 59: 596-601
41 McAdams HP, Rosado-de-Christenson M, Fishback NF,
Templeton PA. Castleman disease of the thorax: radiologic
features with clinical and histopathologic correlation. Radiology
1998; 209: 221-228
42 Ko SF, Wan YL, Ng SH, Lin JW, Hsieh MJ, Fang FM, Lee
TY, Chen WJ. Imaging features of atypical thoracic Castleman
disease. Clin Imaging 2004; 28: 280-285
43 Guihot A, Couderc LJ, Agbalika F, Galicier L, Bossi P,
Rivaud E, Scherrer A, Zucman D, Katlama C, Oksenhendler
E. Pulmonary manifestations of multicentric Castleman’s
disease in HIV infection: a clinical, biological and radiological
study. Eur Respir J 2005; 26: 118-125
44 Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G.
The role of human papilloma virus in lung cancer: a review
287 December 28, 2011|Volume 3|Issue 12|